Viewing Study NCT00542347



Ignite Creation Date: 2024-05-05 @ 6:47 PM
Last Modification Date: 2024-10-26 @ 9:37 AM
Study NCT ID: NCT00542347
Status: TERMINATED
Last Update Posted: 2018-07-20
First Post: 2007-10-09

Brief Title: Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
Sponsor: Queens University
Organization: Queens University

Study Overview

Official Title: Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
Status: TERMINATED
Status Verified Date: 2018-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Enrollment target not met due to high number of disqualified studies
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Proton pump inhibitors PPI are used to decrease stomach acid secretion A generic form of omeprazole one of the PPIs is on the market With cheaper than brand name PPIs it is unclear whether generic omeprazole is as effective clinically This study compares generic omeprazole with half-dose esomeprazole the strongest brand name PPI The half-dose esomeprazole is in fact cheaper than generic omeprazole Healthy volunteers will take each medication in turn for 7 days and their stomach acid will be measured while taking each medication We hypothesize that half-dose esomeprazole is better at suppressing stomach acid than generic omeprazole
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None